A federal judge has posed some pointed questions for a hearing Wednesday where he will consider whether to grant preliminary approval to a Bayer-proposed settlement for a so-called “futures class” of plaintiffs who contract non-Hodgkin lymphoma.
Your Agri-Pulse trial will expire in less than two weeks.
To continue receiving full access to Agri-Pulse reporting, newsletters, podcasts and subscriber-exclusive content, visit our subscription page to choose a monthly or annual membership plan.
Questions about pricing or eligibility for discounted rates? Email paige@agri-pulse.com.